Paul Tudor Jones Takeda Pharmaceutical CO LTD Transaction History

Tudor Investment Corp Et Al

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$13.36 - $15.43 $250,152 - $288,911	18,724 New	18,724 $267,000
Q2 2023 Aug 14, 2023	BUY	$15.57 - $17.11 $932,284 - $1.02 Million	59,877 Added 53.97%	170,818 $2.68 Million
Q1 2023 May 15, 2023	BUY	$15.28 - $16.48 $1.7 Million - $1.83 Million	110,941 New	110,941 $1.83 Million
Q1 2020 May 15, 2020	SELL	$13.02 - $20.31 $5.7 Million - $8.89 Million	-437,923 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$16.88 - $20.83 $24,492 - $30,224	1,451 Added 0.33%	437,923 $8.64 Million
Q3 2019 Nov 14, 2019	BUY	$16.15 - $17.99 $7.05 Million - $7.85 Million	436,472 New	436,472 $7.51 Million
Q2 2019 Aug 14, 2019	SELL	$16.58 - $20.49 $21.2 Million - $26.2 Million	-1,279,098 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$16.7 - $21.52 $21.4 Million - $27.5 Million	1,279,098 New	1,279,098 $26.1 Million

337

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.